Evidence from cancer cell lines have indicated that OA may activate PI3K by binding to the G protein-coupled receptors (GPCR, such as GPCR40 and 120), leading to transactivation of epidermal growth factor receptors via Src, activating a wide variety of pathways including PI3K/Akt [29, 30]. This evidence concerns the gene AKT1 and cancer.